Colorectal Carcinoma — Trials

Colorectal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,010 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 344
Recruiting: 194
Ph III recruiting: 12
Growth YoY: +2.3%
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (127)

clinicaltrialsPublishedShowing 401–419 of 419 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06115733	Study of Fuquinitinib Combined With Capecitabine First-line Maintenance in the Treatment of Metastatic Colorectal Cancer	not yet recruiting	N/A	56	Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER	0	Nov 3, 2023	clinicaltrials
NCT06116019	Online Adaptive Radiotherapy Using a Novel Linear Accelerator (ETHOS)(ART-02)	recruiting	—	649	Charite University, Berlin, GermanyOTHER